Walter & Keenan Wealth Management’s Novartis NVS Stock Holding History

Walter & Keenan Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$418K	Sell	2,670 -7	-0.3%	-$1.05K	0.1%	115
2026 Q1	$409K	Buy	2,677 +30	+1%	+$4.6K	0.12%	115
2025 Q4	$365K	Buy	2,647 +52	+2%	+$6.81K	0.1%	126
2025 Q3	$333K	Buy	2,595 +45	+2%	+$5.49K	0.09%	127
2025 Q2	$309K	Sell	2,550 -1,000	-28%	-$113K	0.09%	129
2025 Q1	$396K	Hold	3,550	–	–	0.12%	118
2024 Q4	$345K	Sell	3,550 -600	-14%	-$64K	0.1%	121
2024 Q3	$477K	Hold	4,150	–	–	0.15%	107
2024 Q2	$442K	Sell	4,150 -474	-10%	-$47.6K	0.14%	105
2024 Q1	$447K	Hold	4,624	–	–	0.15%	105
2023 Q4	$467K	Hold	4,624	–	–	0.17%	101
2023 Q3	$471K	Sell	4,624 -1,600	-26%	-$162K	0.18%	101
2023 Q2	$628K	Hold	6,224	–	–	0.23%	89
2023 Q1	$573K	Hold	6,224	–	–	0.22%	92
2022 Q4	$565K	Hold	6,224	–	–	0.22%	86
2022 Q3	$473K	Sell	6,224 -1,150	-16%	-$95.3K	0.2%	91
2022 Q2	$623K	Sell	7,374 -100	-1%	-$8.77K	0.25%	83
2022 Q1	$656K	Hold	7,474	–	–	0.22%	83
2021 Q4	$654K	Hold	7,474	–	–	0.21%	82
2021 Q3	$611K	Hold	7,474	–	–	0.21%	89
2021 Q2	$682K	Hold	7,474	–	–	0.24%	84
2021 Q1	$639K	Hold	7,474	–	–	0.23%	86
2020 Q4	$706K	Hold	7,474	–	–	0.26%	81
2020 Q3	$650K	Hold	7,474	–	–	0.26%	82
2020 Q2	$653K	Buy	+7,474	New	+$645K	0.26%	80
2020 Q1	–	Sell	-7,474	Closed	-$708K	–	167
2019 Q4	$708K	Hold	7,474	–	–	0.27%	80
2019 Q3	$649K	Hold	7,474	–	–	0.25%	83
2019 Q2	$682K	Buy	7,474 +416	+6%	+$35.2K	0.3%	73
2019 Q1	$608K	Buy	7,058 +250	+4%	+$20.1K	0.27%	79
2018 Q4	$523K	Hold	6,808	–	–	0.24%	82
2018 Q3	$526K	Hold	6,808	–	–	0.16%	92
2018 Q2	$461K	Sell	6,808 -558	-8%	-$38.5K	0.2%	96
2018 Q1	$534K	Sell	7,366 -17,632	-71%	-$1.34M	0.23%	89
2017 Q4	$1.88M	Sell	24,998 -279	-1%	-$21.1K	0.79%	39
2017 Q3	$1.95M	Hold	25,277	–	–	0.9%	34
2017 Q2	$1.89M	Hold	25,277	–	–	0.95%	34
2017 Q1	$1.68M	Hold	25,277	–	–	0.87%	41
2016 Q4	$1.65M	Buy	25,277 +279	+1%	+$18.1K	0.88%	38
2016 Q3	$1.77M	Hold	24,998	–	–	0.98%	36
2016 Q2	$1.85M	Buy	24,998 +279	+1%	+$19.3K	1.03%	35
2016 Q1	$1.6M	Buy	24,719 +223	+0.9%	+$15.2K	0.92%	36
2015 Q4	$1.89M	Hold	24,496	–	–	1.1%	32
2015 Q3	$2.02M	Hold	24,496	–	–	1.25%	25
2015 Q2	$2.16M	Hold	24,496	–	–	1.25%	26
2015 Q1	$2.16M	Hold	24,496	–	–	1.23%	27
2014 Q4	$2.03M	Hold	24,496	–	–	1.16%	28
2014 Q3	$2.07M	Hold	24,496	–	–	1.21%	24
2014 Q2	$1.99M	Buy	24,496 +279	+1%	+$21.9K	1.04%	30
2014 Q1	$1.84M	Buy	+24,217	New	+$1.76M	1.01%	35

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Walter & Keenan Wealth Management's NVS Position: Q2 2026 in Review

Walter & Keenan Wealth Management reduced its Novartis (NVS) stake by 0.26% in Q2 2026, selling an estimated $1.05K and leaving 2,670 shares worth $418K. The position accounts for 0.1% of the portfolio, ranked #115.

Walter & Keenan Wealth Management first reported a position in NVS in Q1 2014 and has held it in 49 quarters since. The position peaked at $2.16M in Q1 2015. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Walter & Keenan Wealth Management held 2,670 shares of Novartis worth $418K as of Q2 2026.
Walter & Keenan Wealth Management sold 7 Novartis shares in Q2 2026, an estimated $1.05K.
Novartis made up 0.1% of Walter & Keenan Wealth Management's portfolio in Q2 2026, its #115 holding.
Walter & Keenan Wealth Management first reported a position in Novartis in Q1 2014 and has held it in 49 quarters since.
Walter & Keenan Wealth Management's Novartis position peaked at $2.16M in Q1 2015.
1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Walter & Keenan Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.